1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Zealand Pharma A/S
  6. News
  7. Summary
    ZEAL   DK0060257814

ZEALAND PHARMA A/S

(ZEAL)
  Report
Delayed Nasdaq Copenhagen  -  10:59 2022-08-15 am EDT
124.30 DKK   +5.34%
11:01aEuropean ADRs Move Sharply Lower in Monday Trading
MT
08/12European ADRs Move Slightly Lower in Friday Trading
MT
08/11European ADRs Move Lower in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Wednesday Trading

05/18/2022 | 11:14am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 1.26% 2.41 Delayed Quote.-35.73%
AKARI THERAPEUTICS, PLC 1.00% 1.5 Delayed Quote.0.00%
AMARIN CORPORATION PLC 1.21% 1.67 Delayed Quote.-50.45%
AUTOLUS THERAPEUTICS PLC 5.32% 3.76 Delayed Quote.-27.55%
BICYCLE THERAPEUTICS PLC 0.57% 26.4 Delayed Quote.-56.63%
DBV TECHNOLOGIES 3.51% 5.165 Real-time Quote.68.85%
EDAP TMS S.A. 2.27% 7.66 Delayed Quote.27.88%
LOGITECH INTERNATIONAL S.A. -0.58% 54.96 Delayed Quote.-28.10%
MEREO BIOPHARMA GROUP PLC -3.70% 1.3 Delayed Quote.-18.75%
OPERA LIMITED -2.94% 4.95 Delayed Quote.-29.89%
SAP SE 0.28% 93.29 Delayed Quote.-25.31%
SEQUANS COMMUNICATIONS S.A. 0.00% 3.4 Delayed Quote.-28.27%
TELEFÓNICA, S.A. -0.91% 4.234 Delayed Quote.9.92%
TRINITY BIOTECH PLC -2.13% 1.38 Delayed Quote.-3.50%
WPP PLC 1.58% 824.6 Delayed Quote.-26.34%
ZEALAND PHARMA A/S 5.34% 124.3 Delayed Quote.-18.68%
All news about ZEALAND PHARMA A/S
11:01aEuropean ADRs Move Sharply Lower in Monday Trading
MT
08/12European ADRs Move Slightly Lower in Friday Trading
MT
08/11European ADRs Move Lower in Thursday Trading
MT
08/11TRANSCRIPT : Zealand Pharma A/S, Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11Zealand Pharma H1 Net Operating Loss Narrows on Lower Revenue; Plans to Remove ADSs Fro..
MT
08/11Zealand Pharma Announces Financial Results for the First Half of 2022
GL
08/11Zealand Pharma Announces Financial Results for the First Half of 2022
AQ
08/11Zealand Pharma A/S Revises Revenue Guidance for the Full Year of 2022
CI
08/11Zealand Pharma A/S Reports Earnings Results for the Second Quarter and Six Months Ended..
CI
08/10European ADRs Climb Higher in Wednesday Trading
MT
More news
Analyst Recommendations on ZEALAND PHARMA A/S
More recommendations
Financials
Sales 2022 134 M 18,4 M 18,4 M
Net income 2022 -1 104 M -151 M -151 M
Net cash 2022 660 M 90,5 M 90,5 M
P/E ratio 2022 -3,52x
Yield 2022 -
Capitalization 5 751 M 788 M 788 M
EV / Sales 2022 38,0x
EV / Sales 2023 10,6x
Nbr of Employees 237
Free-Float 92,0%
Chart ZEALAND PHARMA A/S
Duration : Period :
Zealand Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZEALAND PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 124,30 DKK
Average target price 222,80 DKK
Spread / Average Target 79,2%
EPS Revisions
Managers and Directors
Adam Sinding Steensberg President & Chief Executive Officer
Matthew D. Dallas Chief Financial Officer & Senior Vice President
Alf Gunnar Martin Nicklasson Chairman
Ivan M. Møller Executive VP-Technical Development & Operations
Danilo Verge Head-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
ZEALAND PHARMA A/S-18.68%753
GILEAD SCIENCES, INC.-13.29%78 912
VERTEX PHARMACEUTICALS34.12%75 532
REGENERON PHARMACEUTICALS, INC.-0.45%67 214
WUXI APPTEC CO., LTD.-20.33%40 830
BIONTECH SE-37.80%38 968